At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Use of Novel Sinusonic Device for Prevention of Community Acquired Upper Respiratory (URI)
In Brief
A clinical study evaluating SinuSonic Device and Sham SinuSonic Device for Upper Respiratory Infection. Completed, enrolled 95 participants across 1 site.
Detailed Summary
This study aims to test the safety, efficacy and potential mechanism of action of the SinuSonic device on adults with upper respiratory infection (URI). SinuSonic is a medical device that utilizes sound and pressure combined with normal breathing. The study will have 2 aims. Aim 1 willdetermine if Sinusonic decreases the number of URIs experienced during an 8 week fall URI season. Subjects will use an active device (positive expiratory pressure and 128 Hz) or a sham device (no positive expiratory pressure and 1,000 Hz) for 1 min tid for 8 weeks. Aim 2 will determine if Sinusonic decreases the severity and duration of community acquired viral URIs. Subjects will use active or sham device as above.
Study Details
Timeline
Interventions
A medical device that utilizes sound and pressure combined with normal breathing to relieve nasal congestion.
Sham positive expiratory pressure intervention using the SinuSonic Device.